Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Post-marketing Renal Safety Surveillance Registry in Subjects With Chronic Hepatitis B (HBV) Infection With Decompensated Liver Disease Receiving Nucleotide/Side Therapy

NCT01590615 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT01590615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Post-marketing Renal Safety Surveillance Registry in Subjects With Chronic Hepatitis B (HBV) Infection With Decompensated Liver Disease Receiving Nucleotide/Side Therapy
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
April 26, 2012
Completion date
April 4, 2017
Enrollment
54 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b